Zacks: Valeritas Holdings, Inc. (VLRX) Given Average Rating of “Strong Buy” by Analysts
Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) have been assigned an average broker rating score of 1.00 (Strong Buy) from the two analysts that cover the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy recommendation.
Brokerages have set a 1 year consensus target price of $13.50 for the company, according to Zacks. Zacks has also given Valeritas an industry rank of 187 out of 265 based on the ratings given to its competitors.
Separately, ValuEngine upgraded Valeritas from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd.
WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2018/03/14/zacks-valeritas-holdings-inc-vlrx-given-average-rating-of-strong-buy-by-analysts.html.
Valeritas Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.